MCF Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$549K Buy
+2,059
New +$558K 0.02% 239
2025
Q4
Sell
-11
Closed -$3.16K 1167
2025
Q3
$3.16K Buy
+11
New +$2.95K ﹤0.01% 852
2025
Q1
Sell
-93
Closed -$21.4K 974
2024
Q4
$21.4K Hold
93
﹤0.01% 549
2024
Q3
$20.8K Sell
93
-1
-1% -$220 ﹤0.01% 545
2024
Q2
$19.1K Buy
94
+1
+1% +$203 ﹤0.01% 548
2024
Q1
$20.4K Buy
93
+1
+1% +$220 ﹤0.01% 529
2023
Q4
$20.9K Hold
92
﹤0.01% 495
2023
Q3
$18.4K Sell
92
-14
-13% -$2.95K ﹤0.01% 499
2023
Q2
$22.1K Hold
106
﹤0.01% 465
2023
Q1
$20.9K Hold
106
﹤0.01% 469
2022
Q4
$21.4K Sell
106
-5
-5% -$977 ﹤0.01% 440
2022
Q3
$19K Buy
111
+2
+2% +$409 ﹤0.01% 466
2022
Q2
$22K Hold
109
﹤0.01% 430
2022
Q1
$25K Buy
+109
New +$25.6K ﹤0.01% 426
2021
Q4
Sell
-109
Closed -$26K 405
2021
Q3
$26K Buy
109
+4
+4% +$1.01K ﹤0.01% 380
2021
Q2
$25K Hold
105
﹤0.01% 366
2021
Q1
$23K Hold
105
﹤0.01% 348
2020
Q4
$18K Hold
105
﹤0.01% 348
2020
Q3
$17K Hold
105
﹤0.01% 335
2020
Q2
$15K Hold
105
﹤0.01% 332
2020
Q1
$11K Buy
+105
New +$15.1K ﹤0.01% 362

Other funds holding LH

MCF Advisors's LH Position: Q1 2026 in Review

MCF Advisors opened a new position in Labcorp (LH) in Q1 2026: 2,059 shares worth $549K. The stake represents 0.02% of the portfolio and ranks #239 among its holdings. This is a return to the name: MCF Advisors previously reported a position in LH as recently as Q3 2025.

MCF Advisors first reported a position in LH in Q1 2020 and has held it in 21 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • MCF Advisors held 2,059 shares of Labcorp worth $549K as of Q1 2026.
  • Labcorp was a new MCF Advisors position in Q1 2026.
  • Labcorp made up 0.02% of MCF Advisors's portfolio in Q1 2026, its #239 holding.
  • MCF Advisors first reported a position in Labcorp in Q1 2020 and has held it in 21 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.